LTF and irritable bowel syndrome: Fecal calprotectin and lactoferrin are more likely to reflect luminal pathology than serological markers and have been shown to help differentiate between IBD and IBS, when used in conjunction with symptoms based (Rome/Manning) criteria [16]–[19].